Tina Woods

Founder & CEO, Collider Health, Secretariat for All-Party Parliamentary Group for Longevity, London, UK

Tina Woods is a mission-driven social entrepreneur and system architect bringing diverse stakeholders together in shared endeavours to improve and level up health. She is the Founder and CEO of Collider Health and works with private, public and third sectors. She is the Healthy Longevity Champion for the National Innovation Centre for Ageing aiming to accelerate ageing intelligence and secure UK Research & Innovation´s strategic aims to ensure better health, ageing and wellbeing in the UK and globally.

Tina is Director of the All Party Parliamentary Group for Longevity secretariat and leads the Open Life Data Framework. She is Co-Founder and CEO of Business for Health, a business-led social venture developing a Business Framework for Health, bringing in ´Health´into ´ESG´ mandates to support long-term sustainable innovation and investment in preventative health and care. Tina´s book, ´Live Longer with AI: How artificial intelligence is helping us extend our healthspans and live better too´was published in October 2020.

Tina sits on various advisory groups, including the BSI standards group for AI in health and care, and the Ada Lovelace Advisory Board on Health inequalities. She is also a trustee for the British Society for Research on Ageing.

She studied genetics at Cornell University in the USA and also has an MBA from Bayes Business School (formerly Cass/City).

Tina at the LONGEVITY MED SUMMIT 2023 will introduce at the Track session AI / Digital the lecture:

Quantum Healthy Longevity: connecting healthy people and healthy planet for healthy growth

In her role as Healthy Longevity Champion working with the National Innovation Centre for Ageing (NICA) in the UK, Tina Woods sets out the vision for a ‘Healthy Longevity Innovation Mission’ to harness science, technology, investment and policy for global sustainable impact. This Innovation Mission aims to ensure better health, ageing and wellbeing in the UK and globally, The blueprint for the Innovation Mission is geared to develop UK’s global leadership in science and technology, and support the ambition to aggregate and accelerate a national federated, open, data-driven, knowledge and insight epicentre harnessing ethically-driven AI to scale societal and commercial impact and meet UK’s government’s goal to increase healthy life expectancy and close the gap in health and wellbeing inequalities.

Sign up to receive Longevity Med Summit
and updates